BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 33882200)

  • 1. Clinical characteristics and outcome of hospitalized children and adolescent patients with type 1 diabetes during the COVID-19 pandemic: data from a single center surveillance study in Egypt.
    Sherif EM; Elhenawy YI; Matter RM; Aly HH; Thabet RA; Fereig YA
    J Pediatr Endocrinol Metab; 2021 Jul; 34(7):925-936. PubMed ID: 33882200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency of severe diabetic ketoacidosis at type 1 diabetes onset among children during COVID-19 pandemic lockdown: an observational cohort study.
    Dżygało K; Nowaczyk J; Szwilling A; Kowalska A
    Pediatr Endocrinol Diabetes Metab; 2020; 26(4):167-175. PubMed ID: 33554490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SARS-CoV-2 pandemic is associated with increased severity of presentation of childhood onset type 1 diabetes mellitus: A multi-centre study of the first COVID-19 wave.
    McGlacken-Byrne SM; Drew SEV; Turner K; Peters C; Amin R
    Diabet Med; 2021 Sep; 38(9):e14640. PubMed ID: 34245598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic ketoacidosis at type 1 diabetes diagnosis in children during the COVID-19 pandemic.
    Ho J; Rosolowsky E; Pacaud D; Huang C; Lemay JA; Brockman N; Rath M; Doulla M
    Pediatr Diabetes; 2021 Jun; 22(4):552-557. PubMed ID: 33745226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alarming increase in ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the first wave of the COVID-19 pandemic in Israel.
    Goldman S; Pinhas-Hamiel O; Weinberg A; Auerbach A; German A; Haim A; Zung A; Brener A; Strich D; Azoulay E; Levy-Khademi F; Ludar H; Koren I; Rachmiel M; Yackobovitch-Gavan M; Zuckerman-Levin N; David O; Halloun R; Cahn R; Ben-Ari T; Yeshayahu Y; Landau Z; Phillip M; Lebenthal Y
    Pediatr Diabetes; 2022 Feb; 23(1):10-18. PubMed ID: 34865288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentations, Complications, and Challenges Encountered During Management of Type 1 Diabetes in Egyptian Children During COVID-19 Pandemic: A Single-Center Experience.
    Abdou M; Hassan MM; Hassanein SA; Elsebaie EH; Shamma RA
    Front Endocrinol (Lausanne); 2022; 13():814991. PubMed ID: 35360079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DKA and new-onset type 1 diabetes in Brazilian children and adolescents during the COVID-19 pandemic.
    Luciano TM; Halah MP; Sarti MTA; Floriano VG; da Fonseca BAL; Del Roio Liberatore R; Antonini SR
    Arch Endocrinol Metab; 2022 Mar; 66(1):88-91. PubMed ID: 35029857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Severity of Presentation Signs in Children with Newly Diagnosed Type 1 Diabetes during the COVID-19 Pandemic: A Tertiary Center Experience.
    İzci Güllü E; Akin L; Gökler ME; Aydin M
    Ann Nutr Metab; 2024; 80(3):161-170. PubMed ID: 38479369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic Ketoacidosis and Long-term Insulin Requirements in Youths with Newly Diagnosed Type 2 Diabetes During the SARS-CoV-2 Pandemic.
    Hao S; Cossen K; Westbrook AL; Umpierrez GE; Vellanki P
    Endocr Pract; 2023 Oct; 29(10):754-761. PubMed ID: 37451650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in the Number of Pediatric New-Onset Diabetes and Diabetic Ketoacidosis Cases During the COVID-19 Pandemic.
    Chambers MA; Mecham C; Arreola EV; Sinha M
    Endocr Pract; 2022 May; 28(5):479-485. PubMed ID: 35189332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased paediatric presentations of severe diabetic ketoacidosis in an Australian tertiary centre during the COVID-19 pandemic.
    Lawrence C; Seckold R; Smart C; King BR; Howley P; Feltrin R; Smith TA; Roy R; Lopez P
    Diabet Med; 2021 Jan; 38(1):e14417. PubMed ID: 33020999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic.
    Salmi H; Heinonen S; Hästbacka J; Lääperi M; Rautiainen P; Miettinen PJ; Vapalahti O; Hepojoki J; Knip M
    Arch Dis Child; 2022 Feb; 107(2):180-185. PubMed ID: 34045208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher rates of diabetic ketoacidosis and admission to the paediatric intensive care unit among newly diagnosed children with type 1 diabetes in Kuwait during the COVID-19 pandemic.
    Al-Abdulrazzaq D; Alkandari A; Alhusaini F; Alenazi N; Gujral UP; Narayan KMV; Al-Kandari H;
    Diabetes Metab Res Rev; 2022 Mar; 38(3):e3506. PubMed ID: 34679258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children?
    Rabbone I; Schiaffini R; Cherubini V; Maffeis C; Scaramuzza A;
    Diabetes Care; 2020 Nov; 43(11):2870-2872. PubMed ID: 32778554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the presentation of newly diagnosed type 1 diabetes in children during the COVID-19 pandemic in a tertiary center in Southern Turkey.
    Dilek SÖ; Gürbüz F; Turan İ; Celiloğlu C; Yüksel B
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1303-1309. PubMed ID: 34291625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Children presenting with diabetes and diabetic ketoacidosis to Emergency Departments during the COVID-19 pandemic in the UK and Ireland: an international retrospective observational study.
    Ponmani C; Nijman RG; Roland D; Barrett M; Hulse T; Whittle V; Lyttle MD;
    Arch Dis Child; 2023 Oct; 108(10):799-807. PubMed ID: 37197894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketoacidosis in new-onset type 1 diabetes: did the severity increase during the COVID-19 pandemic?
    Botelho TA; Santos JMN; Pinho CMS; Martins AIBR; Formiga AIS; Serra-Caetano J; Cardoso RCF; Dinis ICAD; Mirante ASR
    J Pediatr Endocrinol Metab; 2022 Jan; 35(1):73-77. PubMed ID: 34766743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal trends in emergency admissions for diabetic ketoacidosis in people with diabetes in England before and during the COVID-19 pandemic: a population-based study.
    Misra S; Barron E; Vamos E; Thomas S; Dhatariya K; Kar P; Young B; Khunti K; Valabhji J
    Lancet Diabetes Endocrinol; 2021 Oct; 9(10):671-680. PubMed ID: 34481558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of COVID-19 on Diabetic Ketoacidosis patients.
    Khan F; Paladino L; Sinert R
    Diabetes Metab Syndr; 2022 Jan; 16(1):102389. PubMed ID: 35016042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency, clinical characteristics, biochemical findings and outcomes of DKA at the onset of type-1 DM in young children and adolescents living in a developing country - an experience from a pediatric emergency department.
    Jawaid A; Sohaila A; Mohammad N; Rabbani U
    J Pediatr Endocrinol Metab; 2019 Feb; 32(2):115-119. PubMed ID: 30699071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.